Re: QBI - QBiotics
Reuben Buchanan?
Is the exit planned during the Phase II trial or upon it's completion?
Is the veterinary market sales and IP belong to the parent company Ecobiotics?
Cheers
Im raising the capital for QBiotics which will go to funding human trials via the FDA. As the OIS states, we are raising $10m so that the drug EBC-46 can enter trials early next year (quite a bit of prep work to do before phase 1 trials start). The trials will be run in Australia and will be to FDA standard. As QBiotics we plan to take EBC-46 through to Phase II and then exit to one of the large pharma groups who is big in Oncology. Phase III gets expensive and can cost up to $500m to run so our strategy is simply to successfully prove the drug in Phase II and then sell.
Registration in the Vet market in Australia is happening now and initial sales will commence in the next 6 months.
No IPO planned as we dont see a need because of the 2 to 3 year exit horizon. And we dont seem to have too many problems raising the funding at the moment. Most Biotechs IPO because they cant raise the funding privately, but IPO is not necessarily the right route for QBiotics at this time.
Reuben Buchanan?
Is the exit planned during the Phase II trial or upon it's completion?
Is the veterinary market sales and IP belong to the parent company Ecobiotics?
Cheers